| Autor: |
Milankumar Patel, Channabasavaiah B. Gurumurthy, Mahmudul Hasan, Santhi Gorantla, Srijanee Das, Linda Chang, Neha Bajwa, Dhruvkumar Soni, Jonathan Herskovitz, St Patrick Reid, Robert Eisenberg, Jatin Machhi, JoEllyn M McMillan, Howard E. Gendelman, Chamindie Punyadeera, Benson J Edagwa, Wilson R. Blomberg, Maxim D. Oleynikov, Bhavesh D. Kevadiya, Ahmed M. Senan |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Journal of Neuroimmune Pharmacology |
| ISSN: |
1557-1904
1557-1890 |
| DOI: |
10.1007/s11481-020-09968-x |
| Popis: |
Graphical abstract The COVID-19 pandemic has affected more than 38 million people world-wide by person to person transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therapeutic and preventative strategies for SARS-CoV-2 remains a significant challenge. Within the past several months, effective treatment options have emerged and now include repurposed antivirals, corticosteroids and virus-specific antibodies. The latter has included convalescence plasma and monoclonal antibodies. Complete viral eradication will be achieved through an effective, safe and preventative vaccine. To now provide a comprehensive summary for each of the pharmacotherapeutics and preventative strategies being offered or soon to be developed for SARS-CoV-2. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink 